Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Mubadala
AddedMar 19, 2024
UpdatedJul 16, 2026
Mubadala

Mubadala

Operating

Global venture capital management with focus on advanced technology investments. Based in Abu Dhabi, San Francisco, and London.

Location
San Francisco, CA, US
Founded
2002
Firm
Compare
Portfolio
Employees
News
Website

Mubadala is a global venture capital management firm with a focus on advanced technology investments. Based in Abu Dhabi, San Francisco, and London, the firm invests across various stages, including Series A, B, C, D, and beyond, as well as private equity and seed rounds. Their portfolio spans diverse sectors such as biotechnology, financial services, and consumer technology.

Notable portfolio companies include Alloy Therapeutics, BetterUp, Klarna, Waymo, and Xpeng. Mubadala's investment philosophy centers on generating sustainable financial returns while fostering innovation. Key partners and decision-makers bring extensive experience from leading global institutions. The firm offers unique value-add services to portfolio companies, including strategic guidance and access to a global network of industry experts.

Mubadala - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments98
Current Portfolio Count67
Total Portfolio Exits2

Top Investment Stages

Series A26 (37.1%)
Series B13 (18.6%)
Series D12 (17.1%)
Private Equity10 (14.3%)
Series C9 (12.9%)

Stage Mix

Series A 37%Series B 19%Series D 17%Private Equity 14%Series C 13%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Andalusia Labs logo

Andalusia Labs

Rejuveron Life Sciences logo

Rejuveron Life Sciences

Georgiamune logo

Georgiamune

EpiBiologics logo

EpiBiologics

Brightspeed logo

Brightspeed

Outpace Bio logo

Outpace Bio

Chroma Medicine logo

Chroma Medicine

Truist Insurance Holdings logo

Truist Insurance Holdings

Paradigm logo

Paradigm

Precision Neuroscience logo

Precision Neuroscience

Resilience logo

Resilience

Vevo Therapeutics logo

Vevo Therapeutics

UpStream Care logo

UpStream Care

Juvena Therapeutics logo

Juvena Therapeutics

Recursion Pharmaceuticals logo

Recursion Pharmaceuticals

Alloy Therapeutics logo

Alloy Therapeutics

Pretzel Therapeutics logo

Pretzel Therapeutics

Spotnana logo

Spotnana

Auron Therapeutics logo

Auron Therapeutics

Flip logo

Flip

Xilis logo

Xilis

Klarna logo

Klarna

Apex Group logo

Apex Group

SpotOn logo

SpotOn

Unlearn.AI logo

Unlearn.AI

Mubadala - Similar Investment Firms

Aramco Ventures logo

Aramco Ventures

Chevron Technology Ventures logo

Chevron Technology Ventures

chevron.com

Mubadala - Classification

Also Known As
  • Mubadala Investment Company Pjsc
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end